Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Institute for bioengineering of Catalonia, IBEC
- Basque Center for Applied Mathematics
- CIC biomaGUNE
- CIC nanoGUNE
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)
- Center for Biological Research "Margarita Salas"-CSIC
- Centre Tecnològic de Telecomunicacions de Catalunya (CTTC)
- Centro de Biotecnología y Genómica de Plantas, CBGP (UPM-INIA)
- FUNDACION INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ
- ICN2
- IDAEA-CSIC
- IMDEA Networks Institute
- IRB Barcelona
- IRTA
- Institut Català de Nanociència i Nanotecnologia
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Institute of Chemical Research of Catalonia ICIQ
- Universidad de Alicante
- Universidade de Vigo
- Universitat de Lleida
- University of Seville
- University of Valencia
- noma de Barcelona
- 14 more »
- « less
-
Field
-
-represented backgrounds. The objective of the research project is to perform Bayesian inversion to characterise the velocity field of 3D partial differential equations describing brain fluid and solute movement
-
Predoctoral researcher at the Targeted Therapeutics & Nanodevices Research Group (Project BRAINZYME)
Generación de Conocimiento by the Spanish Ministry of Science, Innovation and Universities Introduction to the vacant position: The Targeted Therapeutics & Nanodevices Group at the Institute
-
for experiments using reinforcement learning, Bayesian methods, image analysis and data analysis. Collaborate with interdisciplinary teams, including machine learning experts, device modelling specialist
-
molecular sensing. The project also involves studying drug-target interactions with non-canonical DNA structures, leveraging advanced techniques like fluorescence spectroscopy, mass spectrometry, TEM, and NMR
-
therapeutic targets for the disease. Cell cultures and molecular biology techniques will be used to study the underlying mechanisms. The project will be carried out in a hospital setting using human samples
-
from the multistatic system. - Participate in the development of Automatic Target Recognition (ATR) algorithms and methods for identifying dielectric properties. - Contribute to the technical
-
TDP-43 aggregation, decrease stress granules, block exportins avoiding the transport to the cytoplasm, etc. The great challenge is the recovery of TDP-43 homeostasis. In that case, a multi-target
-
target for premature vascular aging in chronic kidney disease and type 2 diabetes" and will perform the following tasks: -Models of vascular calcification in experimental animals. -Study of
-
Universidad de Navarra, we seek to understand the molecular basis underlying the aberrant hematopoietic differentiation that takes place in MDS and AML, with the ultimate goal of finding new therapeutic targets
-
of generating a certain type of organ/cell type. In this way the target organ is formed exclusively from the microinjected stem cells. The group works with mouse and rat embryonic stem cells and human iPS cells